Tempus AI Faces Criticism and Market Uncertainty Amid Short Seller Reports
Tempus AI's stock rebounded after a sharp decline caused by a critical short report from Spruce Point Capital, which questioned the company's AI capabilities and leadership. Tempus responded by dismissing the allegations as inaccurate and misleading, emphasizing its strong financial performance and growth in healthcare AI applications.
